Researchers from Ludwig Maximilian University have developed a simple walking test to diagnose idiopathic normal pressure hydrocephalus, a cause of dementia.
Browsing: Cognitive/neurodegenerative disorders
Findings from a new study – the largest of its kind – indicate that heavy alcohol consumption is the most significant risk factor for the development of dementia.
As more Alzheimer’s research programs are terminated, check out our highlights from the latest neuroscience and neurology industry headlines.
Researchers have observed improvements in the cognitive function of mice after reversing the formation of beta-amyloid plaques.
Discover the factors that inhibit axon regrowth following CNS injury and the potential therapeutics being developed to overome them, in this special report from Future Neurology.
Ruth Wood, co-creator of the Honeycomb maze, describes how the new test overcomes the challenges of its predecessors, and how it can be utilized across the spectrum of neuroscience research.
Discover the genes being targeted by novel Alzheimer’s treatments and how polytherapy may be optimized in treatment of the disease, in this review from Future Neurology.
New research suggests Huntington’s disease may provide protection from cancer.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.
Pharmaceutical policy announcements, promising drug trial data and more: check out our round-up of the biggest news from the neuroscience and neurology industry this week